Miguel Martin - Hosp Gen Univ Gregorio Maranon, Madrid, Spain

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 91 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

Matthew P. Goetz,Erika P. Hamilton,Mario Campone,Sara A. Hurvitz,Javier Cortes,Stephen Johnston,Antonio Llombart-Cussac,Peter A. Kaufman,Masakazu Toi,Guy Jerusalem,Hillary Graham,Hong Wang,Valerie M. Jansen,Lacey M. Litchfield,Miguel Martin

CLINICAL CANCER RESEARCHno. 10 (2024): 2233-2244

引用0浏览0WOS引用

Abstract PO2-20-02: A Phase 3 study of gedatolisib plus fulvestrant with and without palbociclib in patients with HR+/HER2- advanced breast cancer previously treated with a CDK4/6 inhibitor plus a non-steroidal aromatase inhibitor (VIKTORIA-1)

Sara Hurvitz,Fabrice André,Massimo Cristofanilli,Giuseppe Curigliano,Antonio Giordano,Hyo Han,Miguel Martín,Barbara Pistilli,Hope Rugo,Robert Wesolowski,Igor Gorbatchevsky,Sibylle Loibl

Cancer Researchno. 9_Supplement (2024): PO2-20

引用0浏览0引用

Positioning of Tucatinib in the New Clinical Scenario of HER2-Positive Metastatic Breast Cancer: an Italian and Spanish Consensus Paper

Pierfranco Conte,Eva Ciruelos,Giuseppe Curigliano,Michelino De Laurentiis,Lucia Del Mastro,Alessandra Gennari,Antonio Llombart,Miguel Martìn,Francesca Poggio,Aleix Prat,Fabio Puglisi,Cristina Saura

Breast (2024): 103742-103742

引用0浏览0WOS引用

Abstract PO1-19-11: Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer (HER2CLIMB-05, Trial in Progress)

Erika Hamilton,Junji Tsurutani,Giuseppe Curigliano,Miguel Martín,Ciara O'Sullivan, Joo Hyuk Sohn,Konstantinos Tryfonidis,Libero Santarpia,Shan Yang,Véronique Diéras

Cancer Researchno. 9_Supplement (2024): PO1-19

引用0浏览0引用

Ribociclib and Endocrine Therapy As Adjuvant Treatment in Patients with HR+/HER2-early Breast Cancer: Primary Results from the Phase III NATALEE Trial

Daniil J. Stroyakovskiy,Denise A. Yardley,Chiun-Sheng Huang,Peter A. Fasching,John Crown,Aditya Bardia,Stephen Chia,Seock-Ah Im,Miguel Martin,Sherene Loi,Binghe Xu,Sara A. Hurvitz,Carlos Barrios,Michael Untch,Rebecca L. Moroose, Fran Visco,Rodrigo Fresco,Tetiana Taran,Gabriel N. Hortobagyi

Journal of Clinical Oncologyno. 17_suppl (2023): LBA500-LBA500

引用18浏览0引用

Lidera Breast Cancer (BC): Phase III Adjuvant Study of Giredestrant Vs. Physician’s Choice of Endocrine Therapy (PCET) in Patients (pts) with Estrogen Receptor-Positive, HER2-negative Early BC (ER+, HER2– Ebc)

Charles Geyer,Aditya Bardia,Nadia Harbeck,Mothaffar F. Rimawi,Sara A. Hurvitz,Miguel Martin,Sherene Loi,Shigehira Saji,Kyung Hae Jung,Gustavo Werutsky,Daniil Stroyakovskiy,Vanesa Lopez-Valverde,Michael Davis,Tanja Badovinac Crnjevic,Pablo Diego Perez-Moreno,Peter Schmid

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

A Phase 3 Study of Gedatolisib Plus Fulvestrant with and Without Palbociclib in Patients with HR+/HER2-advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor Plus a Non-Steroidal Aromatase Inhibitor (VIKTORIA-1)

Sara Hurvitz,Fabrice Andre,Massimo Cristofanilli,Giuseppe Curigliano,Antonio Giordano,Hyo Han,Miguel Martin,Barbara Pistilli,Hope Rugo,Robert Wesolowski,Igor Gorbatchevsky,Sibylle Loibl

Journal of Clinical Oncologyno. 16_suppl (2023): TPS1118-TPS1118

引用0浏览0引用

Abstract OT2-16-03: Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic breast cancer (HER2CLIMB-05, trial in progress)

Erika Hamilton,Junji Tsurutani,Giuseppe Curigliano,Miguel Martín,Ciara C. O’Sullivan,Joo Hyuk Sohn,Konstantinos Tryfonidis,Libero Santarpia,Shan Yang,Véronique Diéras

Cancer Researchno. 5_Supplement (2023): OT2-16

引用1浏览0引用

Abstract CT063: A Phase 3 Study of Gedatolisib Plus Fulvestrant with and Without Palbociclib in Patients with HR+/HER2- Advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor Plus a Non-Steroidal Aromatase Inhibitor (VIKTORIA-1)

Sara A. Hurvitz,Fabrice André,Massimo Cristofanilli,Giuseppe Curigliano,Antonio Giordano,Hyo S. Han,Miguel Martín,Barbara Pistilli,Hope S. Rugo,Robert Wesolowski,Samuel Suzuki,Sarah C. Mutka,Igor Gorbatchevsky,Sibylle Loibl

Cancer Researchno. 8_Supplement (2023)

引用0浏览0引用

Abstract CT065: Phase 3 Study of Tucatinib or Placebo in Combination with Trastuzumab and Pertuzumab As Maintenance Therapy for HER2+ Metastatic Breast Cancer (HER2CLIMB-05, Trial in Progress)

Erika Hamilton,Junji Tsurutani,Joohyuk Sohn,Giuseppe Curigliano,Ciara C. O’Sullivan,Miguel Martín,Konstantinos Tryfonidis,Libero Santarpia,Shan Yang,Veronique Dieras

Cancer Research（2023）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn